Expression of PD-1 and Tim-3 is increased in skin of patients with bullous pemphigoid and pemphigus vulgaris.
Nancy ErnstM FriedrichK BieberM KasperkiewiczN GrossC D SadikD ZillikensE SchmidtR J LudwigKarin HartmannPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)
Our results suggest exploring immune checkpoint receptors as novel therapeutic targets using an agonistic approach in autoimmune bullous diseases.